The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden

Aim To estimate changes in resource usage, hospitalization rates, and costs in actual practice in Sweden for schizophrenia patients after switching to long-acting injectable risperidone (Risperdal Consta).